ECCO Topical Review

Over the past years, ECCO has successfully published a considerable number of Consensus Guidelines on important topics of IBD. These guidelines will be updated on a regular basis; and there is the strong commitment to ensure user-friendliness. Thus ECCO is striving to contain the number of published Guidelines in order to avoid the publication of too many separate Guidelines manuscripts and to keep the information as concise as possible.

At the same time, the progress of research raises new topics, which ECCO is covering with the new series of publications “ECCO Topical Review”.  These expert reviews are distinct from guideline papers and reserved to areas with yet limited evidence-based information. They focus on a particular topic related to the diagnosis, classification, or management of inflammatory bowel diseases and are authorised by ECCO by following the respective standard operating procedures. Expert opinion consensus endorsed by ECCO is the core feature of this procedure.

ECCO Topical Reviews: Current overview


Topics Call Publication
Fibrosis 2014 February 2016
IBD in the Elderly 2015 November 2016
Environmental Factors in IBD 2015 December 2016
Research Gaps in Diet in IBD


August 2017
Transitional Care in IBD 2016 February 2017
Exit Strategies for IBD Treatments 
2016 August 2017
Complementary Medicine and Psychotherapy 
2017 March 2019
Perioperative Dietary Therapy 2018 September 2019
Optimising Reporting in Surgery, Endoscopy, and Histopathology 2019

January 2021

Clinopathological Spectrum & Differential Diagnosis 2020

Planned May 2021

ECCO-ESGAR: Optimising Reporting in Cross-sectional Imaging 2020 Planned May/June 2021
Refractory IBD 2019 Pending
Biocycle 2022 Early 2023



No video selected.

Posted in Publications


We use cookies

We use cookies on our website. Some of them are essential for the operation of the site, while others help us to improve this site and the user experience (tracking cookies). You can decide for yourself whether you want to allow cookies or not. Please note that if you reject them, you may not be able to use all the functionalities of the site.